Allan Dietz, Ph.D., Director of the Human Cellular Therapy Laboratory (HCTL) at Mayo Clinic, was recently profiled in Mayo Clinic Magazine. The article highlights Dr. Dietz's background and work in the HCTL, which develops cellular therapies to treat a variety of conditions. Dr. Dietz has been a driving force behind the research into medical treatments using cell-based technologies, including adult-derived stem cells known as mesenchymal stem cells.
According to the article, when a physician-scientist explores if stem cells or other cellular therapies could be an option for a patient’s disease or condition, he or she works with Dr. Dietz’s team to develop the protocol and cellular product. This readily available expert support reduces the time it takes to move research from the initial concept to the actual creation of a product that can be tested.
“This is not a solo effort,” Dr. Dietz says. “I really believe that I have the most caring, hardworking team of physicians, scientists, and support staff ever assembled. I am humbled daily by the opportunity to work with them.”
Dr. Dietz and his team have made amazing strides in the HCTL and continue to work hard to meet the needs of patients on a daily basis.
“Science is very much like a farm [where Dr. Dietz grew up]: an endless amount of work and a new flavor of problems every day,” he says. “It is up to us to figure it out.”